ptaquiloside has been researched along with metallothionein in 1 studies
| Studies (ptaquiloside) | Trials (ptaquiloside) | Recent Studies (post-2010) (ptaquiloside) | Studies (metallothionein) | Trials (metallothionein) | Recent Studies (post-2010) (metallothionein) |
|---|---|---|---|---|---|
| 84 | 0 | 35 | 9,390 | 41 | 2,223 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bressan, FF; Caniceiro, BD; da Silva, TC; Fukumasu, H; Gardner, DR; Górniak, SL; Haraguchi, M; Latorre, AO; Lopes, FM; Wysochi, HL | 1 |
1 other study(ies) available for ptaquiloside and metallothionein
| Article | Year |
|---|---|
Ptaquiloside reduces NK cell activities by enhancing metallothionein expression, which is prevented by selenium.
Topics: Animals; Apoptosis; Carcinogens; Down-Regulation; Gene Expression Profiling; Indans; Killer Cells, Natural; Male; Metallothionein; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Pteridium; Selenium; Sesquiterpenes; Spleen; Transcription, Genetic; Transcriptome; Up-Regulation; Zinc | 2013 |